KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Change in Accured Expenses: 2017-2025

Historic Change in Accured Expenses for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to $3.3 million.

  • Guardant Health's Change in Accured Expenses rose 168.44% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.0 million, marking a year-over-year increase of 138.83%. This contributed to the annual value of -$2.8 million for FY2024, which is 154.32% down from last year.
  • As of Q3 2025, Guardant Health's Change in Accured Expenses stood at $3.3 million, which was up 219.77% from -$2.7 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Change in Accured Expenses registered a high of $24.3 million during Q3 2022, and its lowest value of -$28.3 million during Q2 2024.
  • Moreover, its 3-year median value for Change in Accured Expenses was $2.6 million (2023), whereas its average is $125,000.
  • In the last 5 years, Guardant Health's Change in Accured Expenses surged by 646.44% in 2022 and then tumbled by 1,176.35% in 2024.
  • Guardant Health's Change in Accured Expenses (Quarterly) stood at $24.2 million in 2021, then slumped by 43.83% to $13.6 million in 2022, then crashed by 257.08% to -$21.4 million in 2023, then skyrocketed by 179.46% to $17.0 million in 2024, then skyrocketed by 168.44% to $3.3 million in 2025.
  • Its last three reported values are $3.3 million in Q3 2025, -$2.7 million for Q2 2025, and -$1.5 million during Q1 2025.